b-ht 958 has been researched along with methoxamine in 1 studies
| Studies (b-ht 958) | Trials (b-ht 958) | Recent Studies (post-2010) (b-ht 958) | Studies (methoxamine) | Trials (methoxamine) | Recent Studies (post-2010) (methoxamine) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 2,135 | 57 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hörtnagl, H; Kobinger, W; Pichler, L | 1 |
1 other study(ies) available for b-ht 958 and methoxamine
| Article | Year |
|---|---|
B-HT 958, a new alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Cats; Electric Stimulation; Heart; Heart Rate; In Vitro Techniques; Male; Methoxamine; Prazosin; Rats; Synapses; Vagotomy; Yohimbine | 1982 |